Legal Opinion

State v. Teva Pharm. Indus., Ltd.

Louisiana Court of Appeal

Decided February 8, 2018No. 2017 CA 0449PublishedCited by 1 opinion

1Opinion of the CourtPenzato, J.

*596Appellant, State of Louisiana, by and through its Attorney General Jeff Landry (State),1 appeals two judgments of the trial court, which this court assigned two different appellate numbers, sustaining exceptions of no right of action and no cause of action and granting a motion to strike on behalf of defendants, Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Mylan Laboratories, Inc., Mylan Pharmaceuticals, Inc., Ranbaxy Laboratories, Ltd., Ranbaxy Pharmaceuticals, Inc., and Cephalon, Inc., who was subsequently purchased by Teva in 2011 (collectively referred to as…

2Cases cited1 opinion

  1. State v. Teva Pharm. Indus., Ltd.Louisiana Court of Appeal · 2018

3Cited by1 opinion

  1. State v. Teva Pharm. Indus., Ltd.Louisiana Court of Appeal · 2018

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API